Use of adenosine antagonists in the treatment of bradyarrhythmias and mechanical dysfunction associated with cardiopulmonary resuscitation
First Claim
Patent Images
1. A method of enhancing the efficacy of cardiopulmonary resuscitation, comprising:
- applying an electrical defibrillatory shock to a human or animal in cardiac arrest to resuscitate the human or animal;
administering to said human or animal an amount of adenosine antagonist sufficient to alleviate asystole and cardiac arrhythmia associated with said resuscitation, wherein said antagonist is selected from the group consisting of methylxanthines, imidazopyrimidine, pyrazolopyridine, etazolate, pyrazoloquinoline and triazoloquinazoline and wherein said antagonist competitively inhibits adenosine or reduces the level of adenosine present in myocardial tissue and associated fluids.
2 Assignments
0 Petitions
Accused Products
Abstract
A method to enhance the efficacy of cardioversion, defibrillation, cardiac pacing, and cardiopulmonary resuscitation and to treat post-resuscitation asystole, bradyarrhythmias, electromechanical dissociation, and hemodynamic collapse by administering to a human or animal an effective amount of an adenosine antagonist that competitively inhibits adenosine or that reduces the level of adenosine present in myocardial and vascular tissues and associated fluids.
114 Citations
29 Claims
-
1. A method of enhancing the efficacy of cardiopulmonary resuscitation, comprising:
-
applying an electrical defibrillatory shock to a human or animal in cardiac arrest to resuscitate the human or animal; administering to said human or animal an amount of adenosine antagonist sufficient to alleviate asystole and cardiac arrhythmia associated with said resuscitation, wherein said antagonist is selected from the group consisting of methylxanthines, imidazopyrimidine, pyrazolopyridine, etazolate, pyrazoloquinoline and triazoloquinazoline and wherein said antagonist competitively inhibits adenosine or reduces the level of adenosine present in myocardial tissue and associated fluids. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
16. A method for the treatment of post-resuscitation asystole, bradyarrhythmias, electro-mechanical dissociation, and hemodynamic collapse, comprising:
-
applying an electrical difibrillatory shock to a human or animal in cardiac arrest to resuscitate the human or animal; administering to said human or animal an amount of adenosine antagonist sufficient to alleviate asystole, bradyarrhythmias, electromechanical dissociation and hemodynamic collapse associated with said resuscitation wherein said antagonist competitively inhibits adenosine or reduces the level of adenosine present in myocardial tissue and associated fluids. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
Specification